Cargando…

Chromosomal radiosensitivity in G(2)-phase lymphocytes identifies breast cancer patients with distinctive tumour characteristics

A substantial proportion of women with breast cancer exhibit an abnormally high radiosensitivity as measured by the frequency of chromatid breaks induced in G(2)-phase, PHA stimulated lymphocytes. Chromatid break frequencies were compared for a cohort of previously untreated sporadic breast cancer p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riches, A C, Bryant, P E, Steel, C M, Gleig, A, Robertson, A J, Preece, P E, Thompson, A M
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2001
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375149/ https://www.ncbi.nlm.nih.gov/pubmed/11710829 http://dx.doi.org/10.1054/bjoc.2001.2086

Ejemplares similares

Chromosomal radiosensitivity as a marker of predisposition to common cancers?
por: Baria, K, et al.
Publicado: (2001)

Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity
por: Cooper, R A, et al.
Publicado: (1999)

Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity
por: Bennewith, K L, et al.
Publicado: (2001)

Topoisomerase II expression as a determinant of chromosomal radiosensitivity and possible susceptibility in breast cancer
por: Bryant, PE, et al.
Publicado: (2008)

Neuroblastomas with chromosome 11q loss and single copy MYCN comprise a biologically distinct group of tumours with adverse prognosis
por: Luttikhuis, M E M Oude, et al.
Publicado: (2001)

G(2) chromosomal radiosensitivity in Danish survivors of childhood and adolescent cancer and their offspring
por: Curwen, G B, et al.
Publicado: (2005)

Multiple deleted regions on the long arm of chromosome 6 in astrocytic tumours
por: Miyakawa, A, et al.
Publicado: (2000)

Comparative genomic hybridization and chromosomal instability in solid tumours
por: Rooney, P H, et al.
Publicado: (1999)

Radiosensitization of hypoxic tumour cells by S-nitroso-N-acetylpenicillamine implicates a bioreductive mechanism of nitric oxide generation
por: Janssens, M Y, et al.
Publicado: (1999)

Growth and radiosensitivity testing of human tumour cells using the adhesive tumour cell culture system.
por: Parkins, C. S., et al.
Publicado: (1990)

Characterization of antigen-presenting properties of tumour cells using virus-specific cytotoxic T lymphocytes
por: Spierings, D C J, et al.
Publicado: (2000)

Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines
por: Tilborg, A A G van, et al.
Publicado: (1999)

The Effects of X-irradiation and Anti-lymphocyte Serum on the Responses to Tumour Allografts
por: Riches, A. C., et al.
Publicado: (1970)

Numerical and structural aberrations in advanced neuroblastoma tumours by CGH analysis; survival correlates with chromosome 17 status
por: Cunsolo, C Lo, et al.
Publicado: (2000)

RSR13, an allosteric effector of haemoglobin, and carbogen radiosensitize FSAII and SCCVII tumours in C3H mice
por: Khandelwal, S R, et al.
Publicado: (1999)

Association of specific chromosome alterations with tumour phenotype in posterior uveal melanoma
por: Sisley, K, et al.
Publicado: (2000)

Response of human lymphocytes to PHA and tumour-associated antigens as detected by fluorescence polarization.
por: Balding, P., et al.
Publicado: (1980)

In vitro radiosensitivity of tumour cells and fibroblasts derived from head and neck carcinomas: mutual relationship and correlation with clinical data
por: Stausbøl-Grøn, B, et al.
Publicado: (1999)

Evidence for an ependymoma tumour suppressor gene in chromosome region 22pter–22q11.2
por: Hulsebos, T J M, et al.
Publicado: (1999)

Comments on “Response of Human Lymphocytes to PHA and Tumour-Associated Antigens as Detected by Fluorescence Polarization”
por: Preece, A. W., et al.
Publicado: (1980)

Fibroblast radiosensitivity measured using the comet DNA-damage assay correlates with clonogenic survival parameters
por: Eastham, A M, et al.
Publicado: (1999)

Definition of the role of chromosome 9p21 in sporadic melanoma through genetic analysis of primary tumours and their metastases
por: Palmieri, G, et al.
Publicado: (2000)

Serial Irradiation of Mouse Tumours: Changes in Radiosensitivity
por: Pearson, A. E. G.
Publicado: (1959)

Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes
por: Angelis, P M De, et al.
Publicado: (1999)

Biochemotherapy of metastatic malignant melanoma. Predictive value of tumour-infiltrating lymphocytes
por: Håkansson, A, et al.
Publicado: (2001)

Modest radiosensitization of solid tumours in C3H mice by the hypoxic cell radiosensitizer NDPP.
por: Sheldon, P. W., et al.
Publicado: (1975)

Chromosome aberrations in cultured peripheral lymphocytes from persons with elevated skin radiosensitivity.
por: Kondrashova, T V, et al.
Publicado: (1997)

Trafficking of ‘immune’ CD4(+)/CD8(+) T-lymphocytes into the RENCA tumour microcirculation in vivo in mice
por: Ali, S A, et al.
Publicado: (2000)

Some Radiosensitive Tumours
por: Paterson, Ralston
Publicado: (1954)

The influence of chronic anaemia on the radiosensitivity of two mouse tumours.
por: Koong, A. C., et al.
Publicado: (1991)

Enhancement of the radiosensitivity of two human tumour cell lines by hexamethylene bisacetamide.
por: Bill, C. A., et al.
Publicado: (1990)

Tyrphostin AG 1024 modulates radiosensitivity in human breast cancer cells
por: Wen, B, et al.
Publicado: (2001)

Chromosomal imbalances associated with carcinoma in situ and associated testicular germ cell tumours of adolescents and adults
por: Summersgill, B, et al.
Publicado: (2001)

Risk factors for testicular germ cell tumours by histological tumour type
por: Coupland, C A C, et al.
Publicado: (1999)

Potentiation of the anti-tumour effects of Photofrin®-based photodynamic therapy by localized treatment with G-CSF
por: Golab, J, et al.
Publicado: (2000)

High prevalence of p16 genetic alterations in head and neck tumours
por: Miracca, E C, et al.
Publicado: (1999)

Proportion of infiltrating IgG-binding immune cells predict for tumour hypoxia
por: Collingridge, D R, et al.
Publicado: (2001)

HIF-1 and tumour radiosensitivity
por: Moeller, B J, et al.
Publicado: (2006)

Comparing Lymphocyte Radiosensitivity of Prostate Cancer Patients with Healthy Donors Using Micronuclei and Chemical Premature Chromosome Condensation Tests
por: F., Golfam, et al.
Publicado: (2020)

High frequency of chromosome 9 deletion in ovarian cancer: evidence for three tumour-suppressor loci.
por: Devlin, J., et al.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_hr63j350392nr1nejcirr40cj7